1. Home
  2. TNGX vs LVRO Comparison

TNGX vs LVRO Comparison

Compare TNGX & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • LVRO
  • Stock Information
  • Founded
  • TNGX 2014
  • LVRO 2017
  • Country
  • TNGX United States
  • LVRO Brazil
  • Employees
  • TNGX N/A
  • LVRO N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • LVRO Blank Checks
  • Sector
  • TNGX Health Care
  • LVRO Finance
  • Exchange
  • TNGX Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • TNGX 413.6M
  • LVRO 600.5M
  • IPO Year
  • TNGX N/A
  • LVRO N/A
  • Fundamental
  • Price
  • TNGX $3.13
  • LVRO $4.68
  • Analyst Decision
  • TNGX Strong Buy
  • LVRO Buy
  • Analyst Count
  • TNGX 8
  • LVRO 3
  • Target Price
  • TNGX $13.14
  • LVRO $7.17
  • AVG Volume (30 Days)
  • TNGX 1.4M
  • LVRO 11.0K
  • Earning Date
  • TNGX 11-06-2024
  • LVRO 01-22-2025
  • Dividend Yield
  • TNGX N/A
  • LVRO N/A
  • EPS Growth
  • TNGX N/A
  • LVRO N/A
  • EPS
  • TNGX N/A
  • LVRO N/A
  • Revenue
  • TNGX $43,383,000.00
  • LVRO $1,691,812,087.00
  • Revenue This Year
  • TNGX $27.73
  • LVRO N/A
  • Revenue Next Year
  • TNGX N/A
  • LVRO $12.53
  • P/E Ratio
  • TNGX N/A
  • LVRO N/A
  • Revenue Growth
  • TNGX 15.67
  • LVRO 0.48
  • 52 Week Low
  • TNGX $2.70
  • LVRO $3.42
  • 52 Week High
  • TNGX $13.01
  • LVRO $8.87
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 42.05
  • LVRO 43.41
  • Support Level
  • TNGX $2.95
  • LVRO $4.65
  • Resistance Level
  • TNGX $3.20
  • LVRO $5.60
  • Average True Range (ATR)
  • TNGX 0.27
  • LVRO 0.37
  • MACD
  • TNGX 0.08
  • LVRO -0.05
  • Stochastic Oscillator
  • TNGX 72.88
  • LVRO 16.36

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: